GlassScriptPhysician profile
Robert B Nemerofsky
NPI 1629061908
$7,115.52
in general payments reported to CMS, 2019-2025
15 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what 78% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $101 · 2021: $114 · 2022: $242 · 2023: $3,085 · 2024: $2,019 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,203 · Travel and Lodging: $1,185 · Consulting Fee: $38.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,203.41 |
| Travel and Lodging | $1,184.93 |
| Consulting Fee | $38.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $3,534.50 | 2023-2025 | Xperience, Blastx, Surgx |
| W. L. Gore & Associates, INC. | $2,126.74 | 2022-2023 | Gore Bio-A Tissue Reinforcement |
| Smith+Nephew, INC. | $571.48 | 2019-2025 | Collagenase Santyl |
| Convatec INC. | $265.45 | 2023-2025 | |
| Urgo Medical North America, LLC | $143.16 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Merz North America, INC. | $108.60 | 2019-2020 | |
| Kci USA, INC. | $86.41 | 2020-2022 | |
| Biowound Solutions, INC. | $79.07 | 2025 | Bio-Connekt |
| Kerecis Limited | $68.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Reprise Biomedical, INC. | $45.12 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $27.85 | 2023-2024 | |
| Acell, INC. | $20.57 | 2020 | |
| Organogenesis INC. | $18.23 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $14.75 | 2019 | |
| Polarityte, INC. | $5.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nemerofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.